Farzad Abdi-Dezfuli
Direktor/Vorstandsmitglied bei Arxx Therapeutics AS
Ursprung des Netzwerks ersten Grades von Farzad Abdi-Dezfuli
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022.
8
| Subsidiary | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Farzad Abdi-Dezfuli
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of St. Gallen | College/University | Graduate Degree | |
| University of Oslo | College/University | Graduate Degree | |
| ULTIMOVACS ASA | Pharmaceuticals: Major | Director/Board Member | |
K & K AS
 K & K AS Miscellaneous Commercial ServicesCommercial Services K & K AS manages securities. The company was founded on June 26, 2002 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
| Norwegian Cancer Society | Director/Board Member | ||
Arctic Securities AS
 Arctic Securities AS Investment Banks/BrokersFinance Arctic Securities AS is a Norwegian company that provides brokerage services. The private company is based in Oslo, Norway. and has subsidiaries in Norway, Sweden and Germany. The company was founded in 2007 by Jon G. Pedersen, Mads Henrik Syversen. Mads Henrik Syversen has been the CEO since 2007. | Investment Banks/Brokers | Analyst-Equity | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| GENTIAN DIAGNOSTICS | Medical Specialties | Director/Board Member | |
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
P53 Invest AS
 P53 Invest AS Financial ConglomeratesFinance Part of T.D. Veen AS, P53 Invest AS provides investment services for the healthcare industry. The company is based in Oslo, Norway. Susanne Stuffers has been the CEO of the Norwegian company since 2018. | Financial Conglomerates | Chief Executive Officer | |
| EXACT THERAPEUTICS | Biotechnology | Director/Board Member | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Private Equity Analyst | |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| Norwegian University of Science & Technology | College/University | Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
EHA Hoffmann International GmbH
 EHA Hoffmann International GmbH Tools & HardwareConsumer Durables EHA Hoffmann International GmbH is a German company that manufactures hardware products. The private company is based in Siegen, Germany. The CEOs are Sandra Hoffmann, Jörg Klingelhöfer. The company was founded in 1929. | Tools & Hardware | Chief Executive Officer | |
Nadeno Nanoscience AS
 Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
| SOFTOX SOLUTIONS | Miscellaneous Commercial Services | Director/Board Member | |
| Norwegian Pharmaceutical Society | Chairman | ||
| SPAGO NANOMEDICAL AB | Biotechnology | Director/Board Member | |
Aventis Bio-Services, Inc.
 Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The company is based in King of Prussia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CIRCIO HOLDING ASA | Biotechnology | Chief Executive Officer | |
| ORKLA ASA | Food: Specialty/Candy | Director of Finance/CFO | |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Biotechnology | Director/Board Member | |
Liontrust Portfolio Management Ltd.
 Liontrust Portfolio Management Ltd. Investment ManagersFinance Liontrust Portfolio Management Ltd. (LPM) is a specialist fund management boutique headquartered in London, UK. The firm was founded in 2002 by James de Uphaugh, Chris Field, Simon Hazlitt, Rob Harris and Adam Parker. Formerly a subsidiary of Majedie Investment Plc (LSE: MAJE), the firm was acquired by Liontrust Asset Management Plc (LON: LIO) in 2022 and has been renamed under this acquisition from Majedie Asset Management Ltd. to Liontrust Portfolio Management Ltd. LPM manages equity portfolios for institutional clients. Portfolios may be structured as separate managed accounts as well as private funds. | Investment Managers | Analyst-Equity | |
Tema Global Ltd.
 Tema Global Ltd. Investment ManagersFinance Part of Dawn Global Topco Ltd., Tema Global Ltd. is a British company that is building an active thematic ETF platform. The company is based in St. Helier, UK. The platform is dedicated to designing differentiated strategies managed by experienced investment professionals. The company was founded in 2022 by Maurits Henricus Johannes Pot. | Investment Managers | Chief Investment Officer | |
| University of Hamburg | College/University | Doctorate Degree | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Director/Board Member | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
Thelin Hearth Products, Inc..
 Thelin Hearth Products, Inc.. Building ProductsProducer Manufacturing Thelin Co., Inc. manufactures wood, pellet and gas stoves. The firm’s products include hand made stoves. It also offers maintenance services. The company was founded by Thelin Thompson and Terry Thompson in 1978 and is headquartered in Grass Valley, CA. | Building Products | Corporate Officer/Principal | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Founder | |
| University of Duisburg-Essen | College/University | Corporate Officer/Principal | |
| Tachris AG | President | ||
| AOP Orphan International AG | Director/Board Member | ||
| BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Norwegen | 23 |
| Schweiz | 6 |
| Vereinigte Staaten | 5 |
| Deutschland | 4 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 7 |
| Finance | 7 |
| Commercial Services | 3 |
| Consumer Durables | 2 |
Operativ
| Director/Board Member | 24 |
| Chief Executive Officer | 6 |
| Founder | 5 |
| Graduate Degree | 4 |
| Corporate Officer/Principal | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Farzad Abdi-Dezfuli
- Unternehmensverbindungen
